Kamada Confirms KedRAB Supply Amid Rising U.S. Rabies Demand
REHOVOT, Israel and HOBOKEN, N.J. — September 17, 2026 Kamada Ltd. confirmed that it has sufficient KedRAB® inventory and...
infectious disease
Advertisement
Sunshine Biopharma Advances PLpro Inhibitor Toward IND
FORT LAUDERDALE, Fla. — September 16, 2026 Sunshine Biopharma Inc. announced that it has advanced its lead Coronavirus drug...
Cocrystal Pharma Advances CDI-988 in Norovirus Challenge Study
MIAMI, Fla. and BOTHELL, Wash. — September 9, 2026 Cocrystal Pharma, Inc. announced that the last subject has been...
Shionogi Expands Fetroja Role in U.S. Drug-Resistance Preparedness
Osaka, Japan – August 28, 2026 Shionogi & Co., Ltd. announced that the Biomedical Advanced Research and Development Authority...
Pfizer and BioNTech Win FDA Approval for XFG COVID-19 Vaccine
NEW YORK, NY and MAINZ, Germany – August 27, 2026 Pfizer Inc. and BioNTech SE announced that the U.S....
Advertisements
Pfizer and Valneva Secure EMA Validation for Lyme Vaccine
NEW YORK and LYON, France, August 14, 2026 Pfizer Inc. and Valneva SE announced that the European Medicines Agency...
Innoviva Specialty Therapeutics Products Reach Galien Final
WALTHAM, Mass., August 11, 2026 Innoviva Specialty Therapeutics (IST) announced that three of its infectious disease therapies, XACDURO® (sulbactam/durlobactam),...
Intelligent Bio Solutions Completes Clinical Study for FDA 510(k) Submission
NEW YORK, August 11, 2026 Intelligent Bio Solutions Inc. announced the completion of its multi-site Method Comparison Study for...
SNIPR Advances SNIPR001 With Compassionate-Use Clinical Evidence
COPENHAGEN, Denmark, August 12, 2026 SNIPR announced new clinical evidence supporting the translational potential of SNIPR001, its engineered CRISPR-enhanced...
Zepto Life Technology Wins NIAID Contract for FungiFlex
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
Advertisement
